Cancer BiologybioRxiv
Androgen Receptor is a Determinant of Melanoma Targeted Drug Resistance
A. Samarkina, M. K. Youssef, P. Ostano…·G.-P. Dotto
This study shows that androgen receptor activity contributes to melanoma resistance to BRAF/MEK inhibitors and suggests targeting AR could improve treatment outcomes.
DOI 10.1038/s41467-023-42239-w